8 results about "Crataegus" patented technology

The invention belongs to the technical field of biosynthesis of plant secondary metabolites, and particularly relates to a key gene for biosynthesis of large-fruit hawthorn flavonoid compounds and a screening method and application of the key gene. Through combined analysis of metabolome and transcriptome, a key gene combination containing seven structural genes and three transcription factor genes is screened out; the expression of the genes is remarkably positively correlated with the accumulation of a target flavone metabolite [6]-gingerol, and the genes are core factors for regulating and controlling the synthesis of the flavonoid compounds of the big-fruit hawthorns through experimental verification. According to the invention, the key gene for regulating and controlling the synthesis of flavone substances such as [6]-gingerol in the big hawthorn fruit is systematically identified for the first time, and a target spot is provided for analyzing a quality formation mechanism from a molecular level; the gene can be used for molecular marker-assisted breeding so as to cultivate a new variety of large-fruit hawthorn with high flavone content, and also can provide gene resources and technical support for the development of functional food and health care products.

The invention discloses sea-buckthorn, radix astragali and yeast beta-glucan granules and application thereof, and relates to the technical field of food health care, and the sea-buckthorn, radix astragali and yeast beta-glucan granules are prepared from the following raw materials: sea-buckthorn, radix astragali, yeast beta-glucan, American ginseng, radix salviae miltiorrhizae, fructus lycii, flos sophorae, fructus crataegi, xylitol, erythritol, cordyceps militaris, inonotus obliquus, radix polygonati officinalis, rhizoma dioscoreae, radix ophiopogonis and fructo-oligosaccharide. According to the invention, a three-dimensional efficacy system of immune activation, inflammation inhibition and intestinal repair is constructed through scientific proportioning of raw materials such as sea-buckthorn, astragalus membranaceus, yeast beta-glucan, cordyceps militaris and inonotus obliquus. The core components have a synergistic effect, so that not only can the activity of immune cells be activated and the immunity of the organism be improved, but also the release of inflammatory factors can be inhibited, the inflammatory response can be relieved, and meanwhile, the intestinal beneficial bacteria can be proliferated, the intestinal mucosa can be repaired and the intestinal micro-ecology can be improved. Compared with traditional medicinal and edible granules with a single effect, the product can meet the health requirements of people with different constitutions and is richer in adaptive scene.

Provided are a traditional Chinese medicine composition for lipid reduction, a preparation method therefor, and use thereof. The traditional Chinese medicine composition comprises a lipid-reducing core component and auxiliary components. The lipid-reducing core component is composed of Mallotus oblongifolius and Dalbergiae Odoriferae Lignum, and the auxiliary components comprise Crataegi fructus and Salviae miltiorrhizae. The traditional Chinese medicine composition can ameliorate the hyperlipidemia condition and reduce the body weight of model animals, and can also reduce the expression of various inflammatory factors.

To provide a swallowing function-improving agent which contains components different from those of conventional agents and does not remarkably deteriorate the taste and flavor of food and drink.SOLUTION: The agent for improving swallowing function contains at least one kind selected from the group consisting of an extract of Crataegus, an extract of Ginkgo, an extract of Arctium and an extract of Cordyceps sinensis.SELECTED DRAWING: Figure 1

The application relates to an application of a traditional Chinese medicine composition in a drug for chronic obstructive pulmonary disease, characterized in that the traditional Chinese medicine composition comprises the following components in parts: Magnolia officinalis 1-100 parts, Strychnos ignatii 1-100 parts, Toddalia asiatica 1-100 parts, Ephedra 1-100 parts, Amygdalus 1-100 parts, Notopterygium 1-100 parts, Zingiber officinale 1-100 parts, Pogostemonis 1-100 parts, Perilla 1-100 parts, Atractylodes 1-100 parts, Poria cocos 1-160 parts, Atractylodes macrocephala 1-120 parts, Gypsum fibrosum 1-100 parts, Fructus Crataegi 1-100 parts, Fructus Junci 1-100 parts, Fructus Hordei 1-100 parts, Lumbricus 1-100 parts, Radix et Rhizoma Veratri 1-100 parts, Herba Eupatorii Fortunei 1-100 parts, Semen Lepidii 1-100 parts and Semen Platycladi 1-100 parts.

The invention relates to a Shendan pill preparation and a novel preparation method thereof. The invention discloses a combined plant extract. The traditional Chinese medicine composition consists of the following components in parts by weight: a codonopsis pilosula extract, a bighead atractylodes rhizome (stir-fried with bran) extract, a rhizoma polygonati extract, a liquorice extract, a Chinese yam extract, a lotus seed extract, a white hyacinth bean extract, an alpinia katsumadai extract, a pericarpium citri reticulatae extract, a pericarpium citri reticulatae viride (stir-fried with vinegar) extract, a medicated leaven (stir-fried with bran) extract, a rice sprout (stir-fried) extract, a hawthorn (stir-fried) extract and a gordon euryale seed (stir-fried with bran) extract. The invention also discloses a preparation method of the traditional Chinese medicine composition. The whole formula is a herbaceous plant, is a medicinal and edible product (food and herbal medicine) positioned by modern medical management, and has no pharmacological toxicity and accumulated toxicity after being taken for a long time. Through the herbaceous plant combination, the spleen and stomach can be conditioned, vitality is sufficient, meanwhile, the growth of the human body can be promoted, and the body immunity is effectively improved.

The invention provides a traditional Chinese medicine composition as well as a preparation method and application thereof. Specifically, the traditional Chinese medicine composition comprises active ingredients and auxiliary materials, and the active ingredients are prepared from the following raw materials: pollen typhae, radix salviae miltiorrhizae, radix rehmanniae, herba ecliptae, flos chrysanthemi, radix scutellariae, semen cassiae, plantago asiatica, fructus leonuri, fructus ligustri lucidi, spica prunellae, radix gentianae, radix curcumae, herba equiseti hiemalis, radix paeoniae rubra, cortex moutan, fructus crataegi, radix angelicae sinensis and rhizoma chuanxiong; wherein the auxiliary material does not contain dextrin; wherein the content of tanshinol in the traditional Chinese medicine composition is 0.10%-0.20%. The content of tanshinol in the traditional Chinese medicine composition is higher, and the traditional Chinese medicine composition has better efficacy, meets the requirements of the pharmaceutical process, has better fluidity and is more beneficial to preparation of subsequent preparations.

The present application discloses a composition for treating gallstones, which is prepared from the following raw materials in the following weight ratio: 30-60 parts of Herba Artemisiae Scopariae, 10-15 parts of Radix Bupleuri, 10-20 parts of Radix Anemarrhenae, 10-15 parts of Radix Gentianae Macrophyllae, 10-20 parts of Radix Clematidis, 10-15 parts of Rhizoma Sparganii, 10-20 parts of Rhizoma Curcumae, 10-20 parts of Semen Persicae, 10-20 parts of Flos Carthami, 10-15 parts of Rhizoma Chuanxiong, 10-30 parts of Semen Ziziphi Spinosae, 10-15 parts of Scorpio, 15-30 parts of Endothelium Corneum Gigeriae Galli and 10-30 parts of Fructus Crataegi. The composition can relieve the clinical symptoms such as upper abdominal pain, hypochondrium pain, shoulder and back pain caused by hepatobiliary duct stones, improve liver metabolic function disorder, repair hepatobiliary duct pathological stenosis gradually, and prevent the regeneration of hepatobiliary duct stones.